Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

This study has been completed.
Novartis Vaccines
Information provided by:
Novartis Identifier:
First received: August 8, 2009
Last updated: August 10, 2009
Last verified: August 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)